- Type / Class
- Equity / Common Stock
- Shares outstanding
- 235,704,040
- Total 13F shares
- 3,421,139
- Share change
- +79,610
- Total reported value
- $31,680,000
- Price per share
- $9.26
- Number of holders
- 22
- Value change
- +$720,804
- Number of buys
- 13
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Consonance Capital Management LP |
13F
|
Company |
0.42%
|
986,507
|
$9,668,000 | — | 31 Mar 2015 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.41%
|
964,193
|
$9,449,000 | — | 31 Mar 2015 | |
| FMR LLC |
13F
|
Company |
0.18%
|
423,100
|
$4,146,000 | — | 31 Mar 2015 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.15%
|
357,499
|
$3,503,000 | — | 31 Mar 2015 | |
| PointState Capital LP |
13F
|
Company |
0.09%
|
203,158
|
$1,991,000 | — | 31 Mar 2015 | |
| J. Goldman & Co LP |
13F
|
Company |
0.05%
|
121,300
|
$1,189,000 | — | 31 Mar 2015 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.03%
|
77,300
|
$758,000 | — | 31 Mar 2015 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.02%
|
53,100
|
$520,000 | — | 31 Mar 2015 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.02%
|
50,000
|
$490,000 | — | 31 Mar 2015 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.02%
|
41,000
|
$402,000 | — | 31 Mar 2015 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
30,000
|
$294,000 | — | 31 Mar 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
15,400
|
$151,000 | — | 31 Mar 2015 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
13,800
|
$131,000 | — | 31 Mar 2015 | |
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$35,360 | — | 31 Mar 2015 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,000
|
$20,000 | — | 31 Mar 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,165
|
$11,000 | — | 31 Mar 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,007
|
$10,000 | — | 31 Mar 2015 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,000
|
$10,000 | — | 31 Mar 2015 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q2 2015
As of 30 Jun 2015,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,421,139 shares.
The largest 10 holders included
Consonance Capital Management LP, Broadfin Capital, LLC, FMR LLC, FRANKLIN RESOURCES INC, PointState Capital LP, J. Goldman & Co LP, Weiss Multi-Strategy Advisers LLC, Telemetry Investments, L.L.C., Alyeska Investment Group, L.P., and UBS OCONNOR LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2015 vs Q1 2015 Across Filers
Q1 2015 holders
18
Q2 2015 holders
22
Holder diff
4
| Investor | Q1 2015 Shares | Q2 2015 Shares | Share Diff | Share Chg % | Q1 2015 Value $ | Q2 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.